International Conference on Tropical Diseases and Cure

We warmly welcome all Researchers, Scientists, Scholars, and Delegates to join the "International Conference on Tropical Diseases and Cure" on January 23-24, 2023, with the motto “Significant Advancements in Tropical Diseases and Therapies".

This conference will provide a platform for prominent scientists and researchers to exchange ideas and perspectives. There will be masterful keynote speakers as well as well-known leading scientists and professionals from all over the world who will share their thoughts and speak about various aspects of medicine. Our goal is to bring together scholars, young scientists, and industrialists to discuss the issues at hand and the knowledge that still has to be shared. We heartily welcome you to attend in the major medical events of 2023.

Why to attend??

The main objective of the Tropical Diseases 2022 is to bring together leading Oncologists, Medical Experts, Biological Specialists, Radiologists, Immunologists, Clinical Researchers, Undergraduates, General Physicians, Surgeons, Biomarker Associations and Societies, Business Entrepreneurs, Training Institutes, Programming Creating Organizations, Pharmaceutical Companies, Diagnostics Companies, Academic Scientists, and Research Scholars to exchange and share their experiences and research results on all aspects of medicine. It also serves as a key forum for researchers, practitioners, and educators to present and discuss the most recent developments, trends, and concerns in the fields of medicine, as well as practical difficulties faced and solutions readily accessible.

Our Conference will provide a good platform for disseminating information by:

• Innovative talks by the experts of the global scientific community
• Remarkable Awards and Global Recognition to Worthy Researchers
• Global Networking with 50+ Countries across the globe
• Novel Techniques to Benefit Your Research
• Global Business and Networking Opportunities
• Exquisite Platform for showcasing the products and International Sponsorship

Motives to Attend the Tropical Diseases 2023

• Keynote address and interactions to reinvigorate the scientific community
• The Triumph of Awards and Certificates honors your contribution to your profession and encourages new study.
• The Young Scientist/Investigators Award recognises the best emerging young researchers.
• Platform for global investors to engage with professionals in the medical sector.
• Workshops and symposiums to gather the maximum range of medical community participants.

Who to attend:

Students, doctors, scientists, experts, researchers, educators, academicians, physicians, science communicators, healthcare practitioners, product and brand promoters, and all interested in tropical medicine and public-health are welcome to attend.

• Microbiologists
• Pathologists
• Epidemiologists
• Dermatologists
• Allergist
• Immunologists
• Pediatricians
• Physicians

Market Analysis:

The market for diagnosing neglected tropical diseases (NTDs) was estimated to be worth USD 6.09 billion in 2021 and is anticipated to grow at a CAGR of 4.4% during the following five years. Growing public awareness of NTDs and an increase in government activities are expected to boost market expansion. For instance, it is envisaged that the inclusion of NTDs as a worldwide goal in the Sustainable Development Goals (SDG), an initiative of the United Nations Development Program, will spur market expansion. Additionally, a number of WHO efforts, including the Road Map 2030 for the Elimination of NTDs, are anticipated to fuel market expansion throughout the course of the forecast period.

Drugs for Neglected Diseases Initiative (DNDI) and Global Alliance for Vaccines and Immunization (GAVI), two non-profit drug research and development organization’s, are the driving forces behind new drug development and improved treatment access in the market for drugs and vaccines for neglected tropical diseases. With recent regulatory approvals for novel medications and anticipated vaccine launches over the projected period, kinetoplastid illnesses including Chagas and Leishmaniasis present a significant opportunity. Vaccinations in their latter phases of development. Drugs for malaria with an emphasis on shorter regimens to promote patient compliance are among the novel therapeutics in phase III clinical research, whereas the Zika virus and Dengue are still waiting for their first medication treatments.

Beginning in 2020, Takeda's dengue vaccine will be a serious competitor to Dengvaxia. The Bill and Melinda Gates Foundation, for instance. Drug-resistant cases of leishmaniasis and malaria, as well as engagement of funding organization’s supporting treatment expenses in underdeveloped countries, are a few of the diverse factors boosting the market for medications and vaccines for neglected tropical diseases. The Global Drug Facility and GAVI are primarily eligible for funding from participating funding organization’s, which support disease markets that are substantial primarily in low-income endemic countries. The expanding initiatives aimed at raising awareness and expanding access to medications for neglected tropical illnesses are a major element fueling the expansion of the global market for their treatment. Infectious disorders known as neglected tropical diseases are quite common in tropical and subtropical nations. Due to inadequate housing, poor sanitation, and contaminated water, diseases affect rural populations the most frequently. The Tropical Prescription is the component of a medication that deals with medical conditions that frequently occur, progress universally, or become harder to manage in tropical and subtropical regions.